1μg (R: reducing condition, N: non-reducing condition).
Product Details
Product Details
Product Specification
Species | Cynomolgus |
Synonyms | TNFRSF17, CD269, BCM |
Accession | XP_005591343.1 |
Amino Acid Sequence | Met1-Ala53, with C-terminal Fc and Avi Tag |
Expression System | HEK293 |
Molecular Weight | 40-45kDa (Reducing) |
Purity | >95% by SDS-PAGE |
Endotoxin | <0.1EU/μg |
Conjugation | Unconjugated |
Tag | Human Fc Tag, Avi Tag |
Physical Appearance | Lyophilized Powder |
Storage Buffer | PBS, pH7.4. |
Reconstitution | Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation. |
Stability & Storage | · 12 months from date of receipt, lyophilized powder stored at -20 to -80℃. · 3 months, -20 to -80℃ under sterile conditions after reconstitution. · 1 week, 2 to 8℃ under sterile conditions after reconstitution. · Please avoid repeated freeze-thaw cycles. |
Reference | 1. Gene ID: 608, updated on 18-Aug-2023. |
Background
B Cell Maturation Antigen (BCMA) also referred to as TNFRSF17 or CD269, is a transmembrane glycoprotein member of the tumor necrosis factor receptor (TNFR) superfamily. BCMA is a type III membrane protein containing one extracellular cysteine rich domain. TNFRSF17 is expressed in mature B-cells, but not in T-cells or monocytes. This receptor has been shown to specifically bind to the tumor necrosis factor (ligand) superfamily, member 13b (TNFSF13B/TALL-1/BAFF), and to lead to NF-kappaB and MAPK8/JNK activation. This receptor also binds to various TRAF family members, and thus may transduce signals for cell survival and proliferation.
Picture
Picture
SDS-PAGE
ELISA

Immobilized Anti-Human BCMA Monoclonal Antibody (Belantamab) at 2.0μg/mL (100μL/well) can bind Biotinylated BCMA/TNFRSF17 Fc&Avi Tag, Cynomolgus (Cat. No. UA010761)with EC50 of 5.07-8.15ng/mL.
